Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period

References

• Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004;22:419–428.
   PubMedGoogle Scholar
• Berson DS, Chalker DK, Harper JC, Leyden JJ, Shalita AR, Webster GF. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis 2003;72:5–13.
   PubMedGoogle Scholar
• George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg 2008;27:188–196.
   PubMed Web of Science ®Google Scholar
• Archer JS, Chang RJ. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Cl Ob 2004;18:737–754.
   Google Scholar
• Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol 2010;28:17–23.
   PubMed Web of Science ®Google Scholar
• Neri R, Florance K, Koziol P, Van Cleave S. A biological profile of a nonsteroidal antiandrogen, SCH 13521(4′-nitro-3′-trifluoromethylisobutyranilide). Endocrinology 1972;91:427–437.
   PubMed Web of Science ®Google Scholar
• Brogden RN, Clissold SP. Flutamide: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in advanced prostatic cancer. Drugs 1989;38:185–203.
   PubMed Web of Science ®Google Scholar
• Neumann F, Topert M. Pharmacology of antiandrogens. J Steroid Biochem 1986;25:885–895.
   PubMedGoogle Scholar
• Namer M. Clinical applications of antiandrogens. J Steroid Biochem 1988;31:719–729.
   Google Scholar
• Wang HS, Wang TH, Soong YK. Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea. Changgeng Yi Xue Za Zhi 1999;22:423–432.
   PubMedGoogle Scholar
• Carmina E, Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol 2002;57:231–234.
   PubMed Web of Science ®Google Scholar
• Couzinet B, Pholsena M, Young J, Schaison G. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol 1993;39:157–162.
   PubMed Web of Science ®Google Scholar
• Cusan L, Dupont A, Gomez JL, Tremblay RR, Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril 1994;61:281–287.
   PubMed Web of Science ®Google Scholar
• Calaf J, López E, Millet A, Alcañiz J, Fortuny A, Vidal O, Callejo J, Escobar-Jiménez F, Torres E, Espinós JJ. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007;92:3446–3452.
   PubMed Web of Science ®Google Scholar
• Paradisi R, Venturoli S. Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period. Eur J Endocrinol 2010;163:139–147.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456–488.
   PubMed Web of Science ®Google Scholar
• Cremoncini C, Vignati E, Libroia A. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. Acta Eur Fertil 1976;7:299–314.
   PubMedGoogle Scholar
• Paradisi R, Lodi S, Bolelli G, Venturoli S. Radioimmunoassay of three oestrogens and three androgens in the same plasma sample after extraction and chromatographic separation. Eur J Endocrinol 1980;94:229–234.
   Google Scholar
• Paradisi R, Venturoli S, Pasquali R, Capelli M, Porcu E, Fabbri R, Flamigni C. Effects of obesity on gonadotropin secretion in patients with polycyctic ovarian disease. J Endocrinol Invest 1986;9:139–144.
   Google Scholar
• Ibanez L, Potau N, Marcos MV, de Zegher F. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. J Clin Endocrinol Metab 2000;85:3251–3255.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, De Lorenzo D, Ricci C, Fioretti P. Clinical and endocrine effects of flutamide in hyperandrogenic women. Fertil Steril 1993;60:806–813.
   PubMed Web of Science ®Google Scholar
• Moghetti P, Castello R, Negri C, Tosi F, Magnani CM, Fontanarosa MC, Armanini D, Muggeo M. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995;64:511–517.
   PubMed Web of Science ®Google Scholar
• Givens JR, Anderson RN, Wiser WL, Umstot ES, Fish SA. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. Am J Obstet Gynecol 1976;124:333–339.
   PubMed Web of Science ®Google Scholar
• Wysowski DK, Fourcroy JL. Flutamide hepatotoxicity. J Urol 1996;155:209–212.
   PubMedGoogle Scholar
• Takashima E, Iguchi K, Usui S, Yamamoto H, Hirano K. Metabolite profiles in serum from patients with flutamide-induced hepatic dysfunction. Biol Pharm Bull 2003;26:1455–1460.
   Google Scholar
• Wallace C, Lalor EA, Chik CL. Hepatotoxicity complicating flutamide treatment of hirsutism. Ann Intern Med 1993;119:1150 (letter).
   Google Scholar
• Ibáñez L, Jaramillo A, Ferrer A, de Zegher F. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005;20:1833–1836.
   PubMed Web of Science ®Google Scholar
• de Zegher F, Ibanez L. Flutamide for androgen excess: low dose is best. J Pediatr Adol Gynec 2010; doi:10.1016/j.jpag.2010.02.005 (letter).
   Google Scholar
• Bachelot A, Chabbert-Buffet N, Salenave S, Kerlan V, Galand-Portier MB. Anti-androgen treatments. Ann Endocrinol-Paris 2010;71:19–24.
   Google Scholar
• Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997;37:746–754.
   PubMed Web of Science ®Google Scholar
• Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled study. Obstet Gynecol 1997;89:615–622.
   PubMed Web of Science ®Google Scholar
• Yücelten D, Erenus M, Gürbüz O, Durmuşoğlu F. Recurrence rate of hirsutism after 3 different antiandrogen therapies. J Am Acad Dermatol 1999;41:64–68.
   PubMed Web of Science ®Google Scholar